Summary
Helper-inducer (CD29+CD4+) and suppressor (CD45RACD4+) T-cells have been recently renamed as memory and naive T-cells, respectively. We measured cells expressing these phenotypes in peripheral blood of 46 definite multiple sclerosis (MS) patients [32 relapsing-remitting (RR-MS), 14 secondary progressive (P-MS)] and controls. CD25+ (interleukin-2-receptor-positive) cells were also evaluated in the same groups of patients. RR-MS patients showed increased levels of CD29+CD4+ and CD25+ cells compared with controls. This finding was more evident in RR-MS patients during the attack than during the stable phase of the disease. In P-MS patients we found a reduction of CD45+CD4+ cells compared with either RR-MS patients or control subjects. Our results show that RR-MS and P-MS are characterized by two different T-cell subpopulations. This finding supports the hypothesis that during the evolution from RR-MS and P-MS changes occur in the immunological status of the patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Akbar AN, Terry L, Timms A, Beverley PCL, Janossy G (1988) Loss of CD45R and gain of UCHL 1 reactivity is a feature of primed T cells. J Immunol 140:2171–2178
Bellamy AS, Calder VL, Feldmann M, Davison AN (1985) The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes. Clin Exp Immunol 61:248–256
Beverley PCL (1990) Is T cell memory maintained by crossreactive stimulation? Immunol Today 11:203–205
Budd RC, Cerottini JC, MacDonald HR (1987) Phenotypic identification of memory cytolytic T lymphocytes in a subset of Lyt 2+ cells. J Immunol 138:1009–1013
Caldwell CW, Taylor HM (1986) A rapid, no-wash for immunophenotypic analysis by flow cytometry. Am J Clin Pathol 86:600–607
Cantrell DA, Smith KA (1983) Transient expression of interleukin-2 receptors. Consequences for T-cell growth. J Exp Med 158:1895
Clement LT, Yamashita N, Martin A (1988) The functionally distinct subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation dependent post thymic differentiation. J Immunol 41:1454–1470
Gambi D, Porrini AM, Giampictro A, Macor S (1991) CD21+ (B2 antigen +) cell decrement and CD4 + CD29 + (helper-inducer) cell increment suggest an activation of immune system reactivity in multiple sclerosis. J Neuroimmunol 33:97–102
Hofman FM, Von Hanwehr RI, Dinarello CA, Mizel SB, Hinton D, Merril JE (1986) Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J Immunol 136:3239–3245
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452
Ledbetter JA, Rose LM, Spooner CE, Beatty PG, Martin PJ, Clark EA (1985) Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL2 receptor expression. J Immunol 135:1819–1825
McFarlin DE, McFarland HF (1982) Multiple sclerosis. N Engl J Med 307:1183–1188, 1246–1251
Merkenschlager M, Terry L, Edwards R, Beverly PCL (1988) Limiting dilution analysis of proliferative responses in human lymphocyte subpopulations defined by monoclonal antibody UCHL-I: implication for differential CD45 expression in T cell memory formation. Eur J Immunol 18:1653–1658
Morimoto C, Hafler DA, Weiner HL, Letvin NL, Hagan M, Daley J, Schlossman SF (1984) Selective loss of the suppressorinducer T cell subset in progressive multiple sclerosis. N Engl J Med 316:67–72
Morimoto C, Letvin NL, Boyd AW, Hagan M, Brown HM, Kornacki MM, Schlossman SF (1985) The isolation and characterization of the human helper inducer T cell subset. J Immunol 134:3762–3769
Morimoto G, Letvin NL, Distaso JA, Aldrich WR, Schlossman SF (1985) The isolation and characterization of the human suppressor inducer T cell subset. J Immunol 134:1508–1515
O'Gorman M, Oger J (1987) Cell-mediated immune functions in multiple sclerosis. Pathol Immunopathol Res 6:241–272
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. In: Poser CM (ed) The diagnosis of multiple sclerosis. Thieme-Stratton, Stuttgart New York, pp 225–229
Rohowsky-Kochan C, Eiman D, Troiano R, Bansil S, Oleske J, Denny T, Cook SD (1990) Decreased suppressor inducer T lymphocytes in multiple sclerosis and other neurological diseases. J Neuroimmunol 29:161–166
Rose LM, Ginsberg AH, Rothstein TL, Ledbetter JA, Clark EA (1988) Fluctuations of CD4+ T-cell subset in remitting-relapsing multiple sclerosis. Ann Neurol 24:192–199
Sanders ME, Makgoba MW, Shaw S (1988) Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 9:195–198
Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, Nagler B, Sibley WA, Tourtellotte WW, Williman J (1965) Problems of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 122:552–568
Selmay K, Plater-Zyberk C, Rockett KA, Maini RN, Alam R, Perkin GD, Rose FC (1986) Multiple sclerosis: increased expression of interleukin-2 receptors on lymphocytes. Neurology 36:1392–1396
Serra H, Krowka JF, Ledbetter JA, Pilarski LM (1988) Loss of CD45R (Lp220) represent a post-thymic T cell differentiation event. J Immunol 140:1435–1441
Smith SH, Brown MH, Rowe D, Callard RE, Beverley PC (1986) Functional subsets of human helper defined by a new monoclonal antibody, UCHL1. Immunology 58:63–70
Takeuchi T, Schlossman SF, Morimoto C (1987) The 2H4 molecule but not the T3-receptor complex is involved in suppressor inducer signals in the AMLR system. Cell Immunol 107:107–114
Tedder TF, Cooper MD, Clement V (1985) Human lymphocyte differentiation antigens HB-10 and HB-11. Differential production of B cell growth and differentiation factors by distinct helper T cell subpopulations. J Immunol 134:2989–2994
Traugott U, Reinherz EL, Raine CE (1983) Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219:308–310
Trowbridge IS, Omary MB (1981) Human cell surface glycoprotein related to cell proliferation in the receptor for transferrin. Proc Natl Acad Sci USA 78:3039
Waksman BH, Reynolds WE (1984) Multiple sclerosis as a disease of immune regulation. Proc Soc Exp Biol Med 175:282–294
Weiner HL, Hafler DA (1986) Multiple sclerosis. In: Appel SH (ed) Current neurology, vol 6. Year Book Medical Publishers, Chicago, pp 123–151
Zaffaroni M, Rossini S, Ghezzi A, Parma R, Cazzullo CL (1990) Decrease of CD4+CD45 T-cells in chronic-progressive multiple sclerosis. J Neurol 237:1–4
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Porrini, A.M., Gambi, D. & Malatesta, G. Memory and naive CD4+ lymphocytes in multiple sclerosis. J Neurol 239, 437–440 (1992). https://doi.org/10.1007/BF00856808
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00856808